AXNA.F · Amplifon S.p.A

-

Please sign in to comment on AXNA.F

1 Comment

Admin

4 years ago

Amplifon S.p.A is currently in a long term uptrend where the price is trading 17.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.

Amplifon S.p.A's total revenue rose by 1.2% to $513M since the same quarter in the previous year.

Its net income has increased by 27.4% to $60M since the same quarter in the previous year.

Finally, its free cash flow grew by 197.3% to $151M since the same quarter in the previous year.

Based on the above factors, Amplifon S.p.A gets an overall score of 5/5.

Exchange	F
ISIN	IT0004056880
CurrencyCode	EUR
Sector	Healthcare
Industry	Medical Distribution

Market Cap	4B
Beta	0.74
Target Price	None
Dividend Yield	1.7%
PE Ratio	25.11

ABOUT

Amplifon S.p.A

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. It also offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. The company was founded in 1950 and is headquartered in Milan, Italy.

AXNA.F · Amplifon S.p.A

-

Amplifon S.p.A

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Amplifon S.p.A using a moving average strategy